1. ARS PHARMACEUTICA magazine publishes bilingual research works, revision and letters to the editor. All of them in relation to the pharmaceutical science and similars.
ARS PHARMACEUTICA will submit the works received, to their review by anonymous experts. As a result of their report the works will be admitted for their publication wholly, with modifications or refused. In no case whatsoever ARS PHARMACEUTICA will share the views submitted by the authors

 

2. The works in spanish and english will be submitted abiding to the following norms:

2.1. Presentation: Three copies of the work will be submitted. The author will hold on to a copy. The manuscripts shall be typewritten with one and a half spaces between lines, in Courier type letter of ten characters per inch in DIN A4 paper and with a 2.5 cm., margin. Together with the two typed copies, a further copy shall be submitted in a 3 ½ inch diskette written in Word Perfect or Microsoft Word, version 2 or higher, showing on the outside of the diskette the name of the file, or to e-mail: ars@.ugr.es

2.2. Tables and Figures: They should appear at the end of the article, each one on a sheet to themselves, numbered and footnote description meaning.

 

3. Structuring of the articles

3.1 Research work: They should be presented duly structured in the following sections: Introduction, Material and Methods, Results and Discussion/Conclusions.

3.1.1 The extent of the work will not be more than 10 typewritten pages, one and a half space between lines.

3.1.2 Heading. It will be as short and concise as possible (max. 50 characters), reflecting the essential of the content.

3.1.3.Department or Institution on where the work was performed, showing its postal address and electronic mail (e-mail).

3.1.4. Authors: Their surname will be written followed by their names initials and the name of their work place.

3.1.5. The work finantial sources: Scholarships, subventions, equipment, drugs, etc.

3.1.6. Summary: It should be a brief and concrete exposition of the fundamental parts of the work. It will not exceed 150 words. It has to be apt so as to be reproduced by a Data Base.

3.1.7. After the summary and by alphabetical order, three to ten key words which will permit the identification of the contents, will be written.

3.1.8. Introduction: Work hypothesis based upon previous experience and the aims of the study, will be expounded. It is advisable to refer only to the most important works.

3.1.9. Material and methods: The proceedings followed will be explained with sufficient detail so as to permit the reproduction of the study by other researchers, overlooking the details of methods already published, for whom bibliographical reference should suffice.

3.1.10.Results: They will be presented in a logical sequence to the text. Unnecesary protocols should be avoided just as repetitions of tables anf figures.

3.1.11.Discussion/Conclutions: It is recomended to structure them in: brief synopsis of the findings, the possible mechanisms implied, comparison with other findings from other studies already published and limitations of the study.

3.1.12.Recognitions: Those persons who have made a significant contribution to the work can be quoted.

3.1.13.Bibliographical references: The bibliography will be quoted following the order that it is mentioned in the work, in arabic numbers and in supra index. Only the references which will supply something to the text, will be included, avoiding thus, exhaustive references. Vancouver´s quoting norms will be followed, for example: Hepler CD, Strand LM. Opportunities and responsabilities of Pharmaceutical Care. Pharm Care Esp 1999; I: 35-47.

 

3.2 Review works

3.2.1. The extent of the article will not exceed 20 sheets, with the one and a half lines spacing. Those reviews with whom the Editorial Committee considers of relevant importance, can exceed the aforementioned number of sheets. 3.2.2. It will be bibliographical compiling works, those that have as an aim the showing of the actual knowledge and developing aspects in the field of the Pharmaceutical Sciences.
3.2.3. These articles should adjust to paragraphs 3.1.2., 3.1.3, 3.1.4., 3.1.7. and 3.1.13.

3.3. Brief Notes

3.3.1. The extension shall not exceed three sheets , one and a half spaced between lines.

3.3.2. The articles will be on today´s themes, based on published articles.

3.4. Letters to the Editor Brief opinion expressions, limited to 300 words, one table and/or figure and up to a maximum of 5 bibliographical references.
There will be two types of letters to the Editor: One, any communication about experiences carried out and that due to its relevance and interest counsels its quick publication. Two, letters of opinion in aspects which hold relation to the profession and the pharmaceutical sciences.

 

4. Work submition
Editorial Staff ARS FARMACEUTICA magazine Pharmacy School Campus Universitario de Cartuja, s/n 18071 GRANADA (Spain) e-mail: ars@ugr.es





DOWNLOAD